Sector Investors News and Insights

Altimmune, Inc.

Bragar Eagel & Squire, P.C. is advising investors about class action lawsuits filed against Equinix, Harbor Diversified, and Altimmune and is urging investors to get in touch with the firm.

XLRE Real Estate, XLV Health Care / / , , ,

Bragar Eagel & Squire, P.C., a well-known law firm specializing in shareholder rights, is notifying investors about ongoing class action lawsuits.

Bragar Eagel & Squire, P.C. is advising investors about class action lawsuits filed against Equinix, Harbor Diversified, and Altimmune and is urging investors to get in touch with the firm. Read More »

, , ,

Bragar Eagel & Squire, P.C. is reminding investors of the class action lawsuits filed against Malibu Boats, Equinix, Harbor Diversified, and Altimmune, and encourages investors to reach out to the firm.

XLRE Real Estate, XLV Health Care, XLY Consumer Discretionary / / , , , , ,

Reminding investors that class actions have been initiated on behalf of shareholders, Bragar Eagel & Squire, P.C., a well-known shareholder rights law firm, issued a statement on May 16, 2024.

Bragar Eagel & Squire, P.C. is reminding investors of the class action lawsuits filed against Malibu Boats, Equinix, Harbor Diversified, and Altimmune, and encourages investors to reach out to the firm. Read More »

, , , , ,

INVESTOR ALERT: Edelson Lechtzin LLP is advising Altimmune, Inc. (NASDAQ: ALT) shareholders who have experienced significant losses to seek legal advice regarding the ongoing securities fraud class action.

XLV Health Care / / ,

Edelson Lechtzin LLP, a prominent class action law firm, is currently looking into potential breaches of federal securities laws by specific officers.

INVESTOR ALERT: Edelson Lechtzin LLP is advising Altimmune, Inc. (NASDAQ: ALT) shareholders who have experienced significant losses to seek legal advice regarding the ongoing securities fraud class action. Read More »

,

© 2025 ETF Sector

Scroll to Top

Subscribe to our Newsletter

Stay updated with the latests analysis and insights fromm etfsector.com